NurseSavvy™
Log inSign Up
spectrum comparison

Digoxin Lifecycle: Therapeutic Use → Toxicity Recognition → Toxicity Management

Digoxin has one of the narrowest therapeutic windows you'll encounter — the margin between "working" and "killing" is razor-thin. The NCLEX expects you to trace the full arc: appropriate administration, the moment you hold the dose, the moment you recognize toxicity, and the moment you escalate to Digibind. Miss any transition point and you've picked the wrong answer.

Master this comparison — play it or drill it.

Practice 18 NCLEX-style questions

Practice now

Comparison

Progression3 stages
Progression — 3 stages
  1. Therapeutic Use

    What's happening
    • ↑ contractility, ↓ heart rate (HF, AFib)
    Key findings
    • Therapeutic level 0.5–2.0 ng/mL
    • Apical pulse 60–100
    • Improved HF symptoms
    Nursing focus
    • ★Hold & assess if apical pulse < 60
    • Check K⁺ — low K⁺ precipitates toxicity
  2. Toxicity Recognition

    What's happening
    • Level exceeds narrow therapeutic range
    Key findings
    • Anorexia, N/V: earliest signs
    • ★Yellow-green halos / blurred vision
    • Bradycardia, dysrhythmias
    • Level > 2.0 ng/mL
    Nursing focus
    • Hold dose, notify provider
    • Stat digoxin level and K⁺
    Escalate when
    • Rising level or new dysrhythmia
  3. Toxicity Management

    What's happening
    • Reverse toxicity, stabilize rhythm & K⁺
    Key findings
    • Hyperkalemia in acute overdose
    • Dialysis does not remove digoxin
    Nursing focus
    • ★Digoxin immune Fab (DigiFab) antidote
    • Correct potassium
    • Continuous ECG monitoring
    Escalate when
    • Lethal dysrhythmia or K⁺ > 5: give Fab

★ marks the fact that sets a column apart.

Clinical Pearl

Hold at HR < 60, suspect at halos and nausea, Digibind at dysrhythmias — that's the whole spectrum.

Component Topics

Ready to master this comparison?

Get a personalized study plan built around this topic — free to try, no card needed.